Aldesleukin Terminated Phase 2 Trials for Neoplasms, Ovarian Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001827p53 Vaccine for Ovarian Cancer